How TIVA Works – PK/PD Basics
Pharmacokinetics (PK)
"What the body does to the drug."
Absorption, distribution, metabolism, elimination.
Example: Propofol is rapidly distributed to the brain (fast onset) but accumulates in fat over time (slow recovery after long infusions).
Pharmacodynamics (PD)
"What the drug does to the body."
- Propofol → unconsciousness.
- Remifentanil → blocks pain.
PK Analogy
PK = How a car's fuel is used (tank size, speed of burning).
PD Analogy
PD = How fast the car actually goes.
Pharmacokinetics: What Your Body Does to Anesthetic Drugs
IV Administration
TIVA drugs enter bloodstream directly. No absorption phase means immediate availability.
Distribution
Drugs move from blood to target organs. Brain receives medication quickly for rapid onset.
Metabolism
Liver breaks down anesthetic agents. Rate affects drug duration and recovery time.
Elimination
Body removes drug metabolites. Slower clearance extends recovery, especially after long cases.
Like filling connected water tanks: drug flows quickly to small tanks (brain) but slowly accumulates in large reservoirs (fat).
Breaking Down the Body: The Three-Compartment Model
The human body processes anesthetic drugs through three distinct compartments, each with different perfusion rates affecting drug distribution:
Central Compartment (V1)
Blood and highly-perfused organs like the brain and heart.
- Rapid drug changes
- First to receive IV medications
- Explains quick onset of anesthesia
First Peripheral (V2)
Moderately perfused tissues like muscle.
- Intermediate drug exchange rate
- Secondary distribution phase
- Affects duration of drug effect
Second Peripheral (V3)
Poorly perfused tissues like fat.
- Slowest drug exchange
- Significant drug accumulation
- Explains delayed recovery after long cases
Key Concepts: Distribution, Clearance, & Context Sensitive Half-Time
These pharmacokinetic principles determine how TIVA medications behave in your patients.
Distribution
Movement of drugs from bloodstream to tissues. Determines onset speed and initial recovery time.
Clearance
Rate at which the body removes drug molecules. Higher clearance means faster elimination.
Context Sensitive Half-Time
Time for blood concentration to decrease by 50% after stopping infusion. Lengthens with longer administration.
Clinical Impact
Remifentanil wakes patients quickly regardless of infusion length. Propofol recovery slows significantly after extended use.
Comparing Common TIVA Drugs: Pharmacokinetic Properties
Understanding the unique properties of each TIVA agent helps anesthesiologists select optimal drugs for specific patients and procedures. The pharmacokinetic profile of each medication directly impacts induction speed, maintenance requirements, and emergence characteristics - all critical factors in tailored anesthetic delivery.
The table below summarizes key pharmacokinetic parameters for common TIVA medications:
Remifentanil's unique esterase metabolism explains its consistent half-time regardless of infusion duration. This provides predictable recovery times even after lengthy cases.
Propofol
While offering rapid induction and initial recovery, propofol's context-sensitive half-time increases substantially after prolonged infusions. This can lead to delayed emergence in lengthy cases, particularly in elderly patients or those with hepatic dysfunction.
Remifentanil
The ultra-short context-sensitive half-time makes remifentanil ideal for cases requiring rapid emergence regardless of case duration. However, this same property necessitates immediate post-operative pain management strategies to prevent analgesic gaps.
Alfentanil
Offers intermediate properties between remifentanil and fentanyl, making it suitable for moderate-length procedures where some residual analgesia post-emergence is desirable.
Fentanyl
The prolonged context-sensitive half-time after extended infusions can provide beneficial post-operative analgesia but may delay awakening and respiratory drive recovery in longer cases.
When combining these agents in TIVA techniques, understanding their complementary and sometimes competing pharmacokinetic profiles allows anesthesiologists to optimize induction, maintenance, and emergence characteristics for different patient populations and surgical requirements.
From Theory to Practice: Applying Pharmacokinetics in TIVA
Understanding how pharmacokinetic principles influence clinical decisions is essential for effective TIVA administration.
Patient Factors
Pharmacokinetics vary significantly between patients.
- Younger patients: Faster distribution and clearance
- Elderly: Lower doses often needed
- Organ dysfunction alters drug metabolism
Infusion Duration
Time impacts drug accumulation and emergence.
- Short cases: Rapid emergence with all agents
- Long infusions: Propofol accumulates in fat
- Remifentanil: Consistent recovery regardless of duration
Clinical Application
PK knowledge enables precise titration.
- Smoother inductions with patient-specific dosing
- Controlled depth during maintenance
- Predictable emergence timing
What Is the Effect-Site Concentration?
The amount of drug present at the target tissue—usually the brain—where clinical effects actually occur.
Blood concentration (V1) ≠ effect-site concentration. This difference explains the delay between drug administration and observed effects.
Think of ordering a meal: money in your wallet isn't what you eat. The food that arrives at your table is what truly matters.
This Explains:
- Lag time between IV administration and clinical response
- Why monitoring plasma levels alone is insufficient
- The importance of equilibration between compartments
Understanding Keo: The Bridge Between Blood and Effect
Keo (pronounced "kee-oh") represents the equilibration rate between blood concentration and effect-site concentration.
Drug Administration
Drug enters bloodstream but hasn't reached target tissue yet.
Equilibration Time
Keo mathematically describes this delay period.
Clinical Effect
Higher Keo values predict faster onset and offset of drug effects.
Understanding Keo helps predict response timing to anesthetic dose adjustments.
The Clinical Impact of Keo
Onset of Action
Faster keo means rapid drug arrival at effect site. This leads to quicker onset of anesthesia.
Recovery Profile
When infusion stops, high keo drugs clear from effect sites rapidly. This enables faster emergence from anesthesia.
Clinical Application
Remifentanil's fast keo allows precise control during surgery. Plan your TIVA strategy around each drug's equilibration rate.
This diagram illustrates how Keo affects drug movement between the blood (plasma) compartment and the effect site (brain). The width and direction of arrows represent the rate of equilibration. Drugs with higher Keo values (like remifentanil) move more rapidly between compartments, resulting in faster onset and offset of clinical effects. Drugs with lower Keo values take longer to reach equilibrium, leading to delayed onset and prolonged duration of action after infusion stops.
Real-World Examples: How Different Drugs Behave
Understanding how different drugs equilibrate between blood and effect site is crucial for precise TIVA administration.
Higher Keo values translate to faster equilibration between compartments, offering more predictable timing of clinical effects.
Pharmacodynamics: How Drugs Produce Their Effects
Pharmacodynamics studies how drugs affect your body at their target site. It explains what the drug does to you, unlike pharmacokinetics which describes what you do to the drug.
For TIVA practitioners, PD principles predict patient responses to anesthetic agents. This includes consciousness level, pain control, and vital sign changes.
1
Drug Concentration
Amount of drug at effect site
2
Receptor Binding
Drug attaches to specific receptors
3
Clinical Response
Like pressing a car's accelerator - more pressure means more speed
Dose–Response: Linking Amount to Effect
Drug effects follow a predictable S-shaped curve as concentration increases at effect sites.
E0 (Baseline)
Starting point before drug effect begins.
EC50
Concentration producing 50% of maximum effect.
Emax
Maximum achievable effect at any dose.
Gamma (γ)
Curve steepness shows sensitivity to concentration changes.
Like smartphone brightness: initial increases make big differences, but changes diminish at higher settings.
Receptor Occupancy: The Gateway to Drug Effects
Drug effects depend on how many receptors they occupy, not simply drug concentration.
- Initial receptor binding creates noticeable clinical effects
- Middle-range occupation produces most significant changes
- High occupancy reaches a ceiling - adding more drug yields minimal gains
Like filling a theater - once seats are nearly full, additional audience members don't change the performance.
Propofol: Achieving Smooth Induction
Propofol enhances GABA activity, producing rapid sedation and consciousness loss with a predictable onset.
Propofol features a steep dose-response curve. Small concentration increases dramatically affect anesthesia depth.
Like a sensitive dimmer switch, propofol requires careful titration to prevent oversedation.
Remifentanil: Fine-Tuning Analgesia
Remifentanil acts as a potent µ-opioid receptor agonist with a shallow dose-response curve. This enables precise control of analgesia without excessive sedation effects.
Unlike propofol's steep curve, remifentanil's shallow profile allows anesthesiologists to make rapid adjustments. Pain control can be modified instantly during procedures with predictable recovery.
Tailoring Anesthesia: From PD Theory to Patient Monitoring
Despite predictive models, individual patient responses vary widely. Clinical monitoring bridges theory with actual patient needs.
1
1
Administer Drug
Initial dose based on PD models and patient factors.
Monitor Effect
Track BIS values, vital signs, and clinical indicators.
Adjust Dose
Fine-tune infusion rates based on real-time feedback.
Achieve Target
Maintain optimal anesthetic depth with minimal side effects.
Like adjusting music volume when entering a quiet room, TIVA requires continuous refinement based on patient responses rather than rigid protocols.
One Size Doesn't Fit All: Patient Variability in PD
Pharmacodynamic responses vary significantly between individuals, requiring personalized approaches to TIVA.
Key Influencing Factors
- Age and weight
- Genetic differences
- Existing medical conditions
- Receptor density variations
These factors create unique PD profiles for each individual.
Clinical Consequences
Two patients receiving identical propofol concentrations may experience dramatically different effects.
An elderly patient might lose consciousness at half the concentration needed for a younger patient.
Implications for TIVA
PD models provide starting points, not final answers.
Continuous monitoring bridges the gap between theory and individual responses.
Individualized titration is essential for safe, effective anesthesia.
TIVA Drug Comparison: Pharmacodynamic Profiles
What Is Target-Controlled Infusion (TCI)?
Target-Controlled Infusion (TCI) represents a sophisticated evolution in anesthetic delivery. It automatically adjusts infusion rates to maintain precise drug concentrations.
Target Setting
Clinician sets desired drug concentration in blood or effect site.
PK Model Calculation
Computer applies Marsh (propofol) or Minto (remifentanil) models to patient data.
3
Automated Delivery
Pump adjusts infusion rates continuously based on predictive algorithms.
Effect Maintenance
System maintains stable drug concentration at target site.
Unlike fixed-rate infusions, TCI incorporates patient factors—age, weight, height, gender—to personalize drug delivery and optimize anesthetic depth.
Why Is TCI Better Than Manual Infusion?
Precision & Consistency
TCI maintains target concentrations with minimal drug level fluctuations.
Enhanced Safety & Efficiency
Achieves rapid induction and controlled emergence from anesthesia.
Individualized Anesthetic Care
Incorporates patient-specific parameters for personalized care.
How Does TCI Work?
Pharmacokinetic Modeling
TCI systems use pharmacokinetic (PK) models, such as the Marsh model for propofol or the Minto model for remifentanil, to predict drug distribution and clearance within the body. These models estimate how a drug will be absorbed, distributed, metabolized, and eliminated based on population averages and patient-specific characteristics.
Calculation & Algorithm
Patient-specific data, including age, weight, height, and gender, are inputted into the TCI system. The system then employs complex algorithms to calculate the initial bolus dose and subsequent infusion rate required to achieve and maintain the target drug concentration in the blood or effect site.
Continuous Adjustment
TCI systems continuously monitor the predicted drug concentration and adjust the infusion rate in real-time to compensate for any discrepancies. This closed-loop feedback mechanism ensures that the clinical effect matches the predicted drug concentration, allowing for precise and stable control of anesthesia.
PROCESS
Enter Patient Data
Input patient's weight, age, height, and gender into the TCI pump.
Set Target Concentration
Target effect-site concentration for desired sedation level.
Automatic Bolus
Pump delivers an initial bolus, rapidly achieving the target concentration.
Continuous Adjustment
TCI system adjusts infusion rate based on surgical stimulation and patient response.